ARTICLE | Clinical News
Sovaldi sofosbuvir/velpatasvir: Phase III data
September 28, 2015 7:00 AM UTC
Top-line data from the open-label, U.S. and Puerto Rican Phase III ASTRAL-4 trial in 267 patients with chronic HCV infection and Child-Pugh class b cirrhosis showed that a fixed-dose oral combination ...